Sato N - Search Results

1

Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer.

Hino M, Sano M, Sato N, Homma K. Hino M, et al. Among authors: sato n. Surg Today. 2008;38(7):585-91. doi: 10.1007/s00595-007-3686-2. Epub 2008 Jul 9. Surg Today. 2008. PMID: 18612781

2

Detection of bone metastases in routine follow-up after treatment for primary breast cancer.

Sato N, Hino M, Sano M. Sato N, et al. Breast Cancer. 2003;10(4):335-40. doi: 10.1007/BF02967654. Breast Cancer. 2003. PMID: 14634512

3

Value of Three-Dimensional Helical CT Image-Guided Planning for Made-to-Order Lumpectomy in Breast Cancer Patients.

Uematsu T, Sano M, Homma K, Sato N. Uematsu T, et al. Among authors: sato n. Breast J. 2004 Jan-Feb;10(1):33-7. doi: 10.1111/j.1524-4741.2004.10102.x. Breast J. 2004. PMID: 14717757

4

[Successful monotherapy with S-1 in three cases of recurrent/advanced breast cancer non-responsive to anthracycline and taxane anticancer drugs].

Sato N, Sano M. Sato N, et al. Gan To Kagaku Ryoho. 2006 Jan;33(1):137-40. Gan To Kagaku Ryoho. 2006. PMID: 16410715 Japanese.

5

Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study.

Sato N, Sano M, Tabei T, Asaga T, Ando J, Fujii H, Yamamoto N, Kurosumi M, Inoue K, Kimura M. Sato N, et al. Breast Cancer. 2006;13(2):166-71. doi: 10.2325/jbcs.13.166. Breast Cancer. 2006. PMID: 16755112 Free article. Clinical Trial.

6

[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial].

Sano M, Tabei T, Suemasu K, Yanagita Y, Yamamoto N, Asaga T, Ando J, Fujii H, Inoue K, Sato N, Takei H, Kurosumi M, Honma K, Kimura M. Sano M, et al. Among authors: sato n. Gan To Kagaku Ryoho. 2006 Oct;33(10):1411-5. Gan To Kagaku Ryoho. 2006. PMID: 17033229 Clinical Trial. Japanese.

7

Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.

Kimura M, Sano M, Fujimori M, Nakagomi H, Negishi T, Yanagita Y, Sato N. Kimura M, et al. Among authors: sato n. Anticancer Res. 2008 Mar-Apr;28(2B):1239-44. Anticancer Res. 2008. PMID: 18505061 Free article. Clinical Trial.

8

[Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].

Yamamoto N, Tabei T, Inoue K, Takei H, Sato N, Yanagita Y, Fujisawa T, Fujii H, Saeki T, Kurosumi M. Yamamoto N, et al. Among authors: sato n. Gan To Kagaku Ryoho. 2010 Jan;37(1):57-63. Gan To Kagaku Ryoho. 2010. PMID: 20087033 Japanese.

9

Relationship between the signal ratios of HER-2/CEP17 and c-MYC/CEP17 and the pathological response of neoadjuvant therapy using docetaxel and trastuzumab in breast cancer.

Kurosumi M, Tabei T, Sano M, Honma K, Yanagita Y, Yamamoto N, Inoue K, Sato N, Kimura M. Kurosumi M, et al. Among authors: sato n. Mol Med Rep. 2008 Jan-Feb;1(1):71-5. Mol Med Rep. 2008. PMID: 21479380

10

Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.

Iwata H, Sato N, Masuda N, Nakamura S, Yamamoto N, Kuroi K, Kurosumi M, Tsuda H, Akiyama F, Ohashi Y, Toi M. Iwata H, et al. Among authors: sato n. Jpn J Clin Oncol. 2011 Jul;41(7):867-75. doi: 10.1093/jjco/hyr081. Jpn J Clin Oncol. 2011. PMID: 21719750 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,482 results

Search Page

Filters